These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19076428)

  • 1. What have PINK1 and HtrA2 genes told us about the role of mitochondria in Parkinson's disease?
    Plun-Favreau H; Gandhi S; Wood-Kaczmar A; Deas E; Yao Z; Wood NW
    Ann N Y Acad Sci; 2008 Dec; 1147():30-6. PubMed ID: 19076428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
    Plun-Favreau H; Klupsch K; Moisoi N; Gandhi S; Kjaer S; Frith D; Harvey K; Deas E; Harvey RJ; McDonald N; Wood NW; Martins LM; Downward J
    Nat Cell Biol; 2007 Nov; 9(11):1243-52. PubMed ID: 17906618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
    Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
    Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo.
    Yun J; Cao JH; Dodson MW; Clark IE; Kapahi P; Chowdhury RB; Guo M
    J Neurosci; 2008 Dec; 28(53):14500-10. PubMed ID: 19118185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
    Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
    Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis.
    Dagda RK; Chu CT
    J Bioenerg Biomembr; 2009 Dec; 41(6):473-9. PubMed ID: 20012177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin.
    Whitworth AJ; Lee JR; Ho VM; Flick R; Chowdhury R; McQuibban GA
    Dis Model Mech; 2008; 1(2-3):168-74; discussion 173. PubMed ID: 19048081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
    Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
    Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Role of Serine Protease HtrA2/Omi in Neurodegenerative Diseases.
    Goo HG; Rhim H; Kang S
    Curr Protein Pept Sci; 2017; 18(7):746-757. PubMed ID: 26965693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin.
    Tain LS; Chowdhury RB; Tao RN; Plun-Favreau H; Moisoi N; Martins LM; Downward J; Whitworth AJ; Tapon N
    Cell Death Differ; 2009 Aug; 16(8):1118-25. PubMed ID: 19282869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.
    Guo M
    Cold Spring Harb Perspect Med; 2012 Nov; 2(11):. PubMed ID: 23024178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
    Krüger R; Sharma M; Riess O; Gasser T; Van Broeckhoven C; Theuns J; Aasly J; Annesi G; Bentivoglio AR; Brice A; Djarmati A; Elbaz A; Farrer M; Ferrarese C; Gibson JM; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Klein C; Lambert JC; Lesage S; Lin JJ; Lynch T; Mellick GD; de Nigris F; Opala G; Prigione A; Quattrone A; Ross OA; Satake W; Silburn PA; Tan EK; Toda T; Tomiyama H; Wirdefeldt K; Wszolek Z; Xiromerisiou G; Maraganore DM;
    Neurobiol Aging; 2011 Mar; 32(3):548.e9-18. PubMed ID: 20036034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding insights of mitochondrial dysfunction in Parkinson's disease.
    Abou-Sleiman PM; Muqit MM; Wood NW
    Nat Rev Neurosci; 2006 Mar; 7(3):207-19. PubMed ID: 16495942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARK13 regulates PINK1 and subcellular relocation patterns under oxidative stress in neurons.
    Patil KS; Basak I; Lee S; Abdullah R; Larsen JP; Møller SG
    J Neurosci Res; 2014 Sep; 92(9):1167-77. PubMed ID: 24798695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation of Omi/HtrA2 and Parkinson's disease.
    Ross OA; Soto AI; Vilariño-Güell C; Heckman MG; Diehl NN; Hulihan MM; Aasly JO; Sando S; Gibson JM; Lynch T; Krygowska-Wajs A; Opala G; Barcikowska M; Czyzewski K; Uitti RJ; Wszolek ZK; Farrer MJ
    Parkinsonism Relat Disord; 2008 Nov; 14(7):539-43. PubMed ID: 18790661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease.
    Wang CY; Xu Q; Weng L; Zhang Q; Zhang HN; Guo JF; Tan LM; Tang JG; Yan XX; Tang BS
    Brain Res; 2011 Apr; 1385():293-7. PubMed ID: 21338583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PINK1 protein in normal human brain and Parkinson's disease.
    Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T
    Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTRA2 variations in Taiwanese Parkinson's disease.
    Chen CM; Wu CH; Hsieh CH; Lin CH; Chen IC; Chen YC; Lee LC; Lee CM; Tseng YC; Lee-Chen GJ; Wu YR
    J Neural Transm (Vienna); 2014 May; 121(5):491-8. PubMed ID: 24337630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.